InsiderTrades

Form 4 for TAK TAKEDA PHARMACEUTICAL CO LTD

Accepted 2026-07-06 18:09:03 ET · period of report 2026-07-01 · accession 0001395064-26-000260 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2026-07-06 18:09 2026-07-01 TAK Furuta Milano CFO, Dir A - Grant $0.00 +12.3K 70.2K +21% $0
D 2026-07-06 18:09 2026-07-10 TAK Furuta Milano CFO, Dir D - Sale to Iss $4,931.50 -16.6K 0 -100% -$81.96M
DM 2026-07-06 18:09 2026-07-01 TAK Furuta Milano CFO, Dir A - Grant $0.00 +12.9K 4,288 New $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Ordinary Shares 2026-07-01 A A 12,300 $0.00 70,200 D — — (F1) Represents an award of restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Common Stock. The RSUs vest in three equal annual installments beginning on June 1, 2027.
2 Derivative Tax Obligation Award 2026-07-10 D D 16,619 $4,931.50 0 D — · 2026-06-01 to 2026-06-01 16,619 Ordinary Shares (F2) Each Tax Obligation Award was the economic equivalent of one Ordinary Share that, upon vest, was converted into to a cash payment primarily to cover tax obligations. Any remaining proceeds from the disposition of the associated Ordinary Shares will be delivered to the reporting person on July 10. (F2) Each Tax Obligation Award was the economic equivalent of one Ordinary Share that, upon vest, was converted into to a cash payment primarily to cover tax obligations. Any remaining proceeds from the disposition of the associated Ordinary Shares will be delivered to the reporting person on July 10. (F3) The price reported in Column 8 is a weighted average price denominated in Yen. These shares were sold in transactions at prices ranging from JPY 4,882 to JPY 5,050, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
3 Derivative Tax Obligation Award 2026-07-01 A A 4,288 $0.00 11,741 D — · 2027-06-01 to 2027-06-01 4,288 Ordinary Shares (F4) Each Tax Obligation Award is the economic equivalent of one Ordinary Share that, upon vest, will be converted to a cash payment primarily to cover tax obligations at the then-current market price of the Ordinary Shares.
4 Derivative Tax Obligation Award 2026-07-01 A A 4,288 $0.00 8,482 D — · 2028-06-01 to 2028-06-01 4,288 Ordinary Shares (F4) Each Tax Obligation Award is the economic equivalent of one Ordinary Share that, upon vest, will be converted to a cash payment primarily to cover tax obligations at the then-current market price of the Ordinary Shares.
5 Derivative Tax Obligation Award 2026-07-01 A A 4,288 $0.00 4,288 D — · 2029-06-01 to 2029-06-01 4,288 Ordinary Shares (F4) Each Tax Obligation Award is the economic equivalent of one Ordinary Share that, upon vest, will be converted to a cash payment primarily to cover tax obligations at the then-current market price of the Ordinary Shares.